RefleXion Medical

RefleXion Medical is a privately held therapeutic oncology company headquartered in Hayward, California, founded in 2009 by Sam Mazin and Akshay Nanduri around the biology-guided radiotherapy (BgRT) concept conceived at Stanford University in 2007. The company designs, manufactures and commercializes the RefleXion X1 radiotherapy platform and SCINTIX biology-guided radiotherapy, which uses onboard PET detectors to sense emissions from an injected radiopharmaceutical and autonomously direct external-beam radiotherapy delivery with sub-second latency. The RefleXion X1 received FDA clearance for SRS, SBRT and IMRT in 2020, and SCINTIX therapy was FDA cleared in February 2023 for treating tumors in the lung or bone arising from primary and metastatic cancer. RefleXion has raised more than $500 million from investors including TPG's The Rise Fund, KCK Group, PSP Investments, Sofinnova, Pfizer Ventures and Johnson & Johnson Innovation. RefleXion is a medical device manufacturer rather than a software vendor and publishes no public developer portal, API documentation, SDKs or machine-readable API contract.

RefleXion Medical is profiled on the APIs.io network. Tagged areas include Company, Healthcare, Medical Devices, Oncology, and Radiation Oncology.

RefleXion Medical’s developer surface includes engineering blog, product news, support, legal docs, YouTube channel, and 28 more developer resources.

17.6/100 emerging ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-08-05 · rubric v0.9.1
0 APIs
CompanyHealthcareMedical DevicesOncologyRadiation OncologyRadiotherapyMedical ImagingCancer Care

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-08-05 · rubric v0.9.1
Composite quality — 17.6/100 · emerging
Contract Quality 0.0 / 25
Developer Ergonomics 1.3 / 20
Commercial Clarity 5.8 / 20
Operational Transparency 0.0 / 13
Governance 1.5 / 12
Discoverability 6.9 / 10
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 10
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
A2A Agent Card 0 / 8
Dry-Run / Simulate Mode 0 / 4
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/reflexion-medical: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Reflexion Medical Domain Security

TLSv1.3 · DMARC

SECURITY

Resources

Agent Surfaces 1

MCP servers, agent skills, and machine-readable catalogs

Design & Contract 1

Pagination, idempotency, versioning, errors, and events

Access & Security 2

Authentication, authorization, and security posture

Learn 2

Tutorials, courses, talks, and written guidance

Operate 3

Status, limits, changes, and where to get help

Commercial 3

Pricing, plans, and the legal terms of use

Company 14

The organization behind the API

Scroll for all 14

Other 7

Properties that don't map to a standard resource type

Scroll for all 7

Source (apis.yml)

apis.yml Raw ↑
aid: reflexion-medical
name: RefleXion Medical
description: RefleXion Medical is a privately held therapeutic oncology company headquartered in Hayward, California, founded
  in 2009 by Sam Mazin and Akshay Nanduri around the biology-guided radiotherapy (BgRT) concept conceived at Stanford University
  in 2007. The company designs, manufactures and commercializes the RefleXion X1 radiotherapy platform and SCINTIX biology-guided
  radiotherapy, which uses onboard PET detectors to sense emissions from an injected radiopharmaceutical and autonomously
  direct external-beam radiotherapy delivery with sub-second latency. The RefleXion X1 received FDA clearance for SRS, SBRT
  and IMRT in 2020, and SCINTIX therapy was FDA cleared in February 2023 for treating tumors in the lung or bone arising from
  primary and metastatic cancer. RefleXion has raised more than $500 million from investors including TPG's The Rise Fund,
  KCK Group, PSP Investments, Sofinnova, Pfizer Ventures and Johnson & Johnson Innovation. RefleXion is a medical device manufacturer
  rather than a software vendor and publishes no public developer portal, API documentation, SDKs or machine-readable API
  contract.
image: https://reflexion.com/wp-content/uploads/2021/08/rx-logo.png
url: https://raw.githubusercontent.com/api-evangelist/reflexion-medical/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: profiled
x-tier-reason: enrichment-pass
x-api-surface: none-published
specificationVersion: '0.20'
created: '2026-08-02'
modified: '2026-08-02'
tags:
- Company
- Healthcare
- Medical Devices
- Oncology
- Radiation Oncology
- Radiotherapy
- Medical Imaging
- Cancer Care
apis: []
x-enrichment:
  date: '2026-08-02'
  status: minimal
  artifacts_added: 4
  pass: local-v1
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/reflexion-medical-domain-security.yml
- type: Website
  url: https://reflexion.com/
- type: About
  url: https://reflexion.com/our-company/
- type: Products
  url: https://reflexion.com/scintix-therapy/
- type: Research
  url: https://reflexion.com/research/
- type: Resources
  url: https://reflexion.com/scintix-therapy/resources/
- type: Blog
  url: https://reflexion.com/our-company/blog/
- type: BlogFeeds
  url: https://reflexion.com/feed/
- type: Newsroom
  url: https://reflexion.com/our-company/newsroom/
- type: PressReleases
  url: https://reflexion.com/our-company/in-the-press/
- type: News
  url: https://reflexion.com/our-company/in-the-news/
- type: Events
  url: https://reflexion.com/our-company/events/
- type: Media
  url: https://reflexion.com/our-company/media-resources/
- type: Videos
  url: https://reflexion.com/our-company/video-downloads/
- type: Newsletter
  url: https://reflexion.com/newsletter/
- type: Careers
  url: https://reflexion.com/our-company/careers/
- type: Team
  url: https://reflexion.com/our-company/leadership/
- type: Support
  url: https://reflexion.com/contact/
- type: Contact
  url: https://reflexion.com/contact/
- type: Legal
  url: https://reflexion.com/legal/
- type: TermsOfService
  url: https://reflexion.com/legal/terms-of-use/
- type: PrivacyPolicy
  url: https://reflexion.com/legal/privacy-policy/
- type: Compliance
  url: https://reflexion.com/legal/compliance-declaration/
- type: Patents
  url: https://reflexion.com/legal/patents/
- type: LinkedIn
  url: https://www.linkedin.com/company/reflexion-medical/
- type: Twitter
  url: https://twitter.com/reflexionmed
- type: Youtube
  url: https://www.youtube.com/c/reflexionmedical
- type: Facebook
  url: https://www.facebook.com/reflexionmedical/
- type: Instagram
  url: https://www.instagram.com/reflexionbgrt/
- type: Crunchbase
  url: https://www.crunchbase.com/organization/reflexion-medical
- type: Investors
  url: https://forgeglobal.com/reflexion-medical_stock/
- type: Conformance
  url: conformance/reflexion-medical-conformance.yml
- type: LLMsTxt
  url: llms/reflexion-medical-llms.txt